These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8815823)

  • 1. [Prevention of coronary disease in clinical practice].
    Vacheron A; Delaye J
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1491. PubMed ID: 8815823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of coronary artery disease.
    N Engl J Med; 1991 Jul; 325(3):203-5. PubMed ID: 2052065
    [No Abstract]   [Full Text] [Related]  

  • 4. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of coronary artery disease. A medical imperative.
    Leaf A; Ryan TJ
    N Engl J Med; 1990 Nov; 323(20):1416-9. PubMed ID: 2233911
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary heart disease. A message from preventive medicine and your physician.
    Prev Med; 2000 Apr; 30(4):269-70. PubMed ID: 10731453
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical Grand Rounds. Preventive cardiology: the physician's role in risk factor reduction.
    Kossmann CE
    J Tenn Med Assoc; 1982 Sep; 75(9):601-7, 609. PubMed ID: 7176637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nation-wide program for the prevention of atherosclerosis. Physicians, patients and health insurance carriers must all pull together].
    Platzer H
    MMW Fortschr Med; 2003 Mar; 145(13):37-8. PubMed ID: 15101531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-Waluś B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategy of the french cardiology association in the prevention of coronary disease].
    Vacheron A
    Arch Mal Coeur Vaiss; 1992 Feb; 85(2):165-7. PubMed ID: 1562217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk factors of myocardial ischemia and role of the physician in its prevention].
    Pezzana M
    Minerva Med; 1991 Mar; 82(3):131-5. PubMed ID: 2006032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single mathematical model predicts physicians' recommendations and postmenopausal women's decisions to participate in a clinical trial to prevent breast cancer or coronary heart disease.
    Veit CT
    Med Decis Making; 2004; 24(4):330-50. PubMed ID: 15271272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The innovative clinical research promoted by the Italian Association of Hospital Cardiologists].
    Magnoni M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):78S-80S. PubMed ID: 20879487
    [No Abstract]   [Full Text] [Related]  

  • 14. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary coronary heart disease prevention in general practice. How does one recognize and define a risk patient?].
    Schwandt P
    MMW Fortschr Med; 1999 Oct; 141(43):26-8. PubMed ID: 10912117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of low-dose aspirin as a preventive measure.
    Rees MK
    Am Fam Physician; 1995 Sep; 52(3):766, 768, 775. PubMed ID: 7653416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action plan for prevention of coronary disease in Europe].
    de Velasco Rami JA
    Rev Esp Cardiol; 1995 Dec; 48(12):781-2. PubMed ID: 8685498
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione].
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Ital Heart J Suppl; 2000 May; 1(5):692-8. PubMed ID: 10834137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.